Highland Capital Management (Texas)’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Highland Capital Management (Texas)’s Portfolio RPTP Stock Details RPTP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-169,600	Closed	-$781K	–	314
2016 Q1	$781K	Buy	+169,600	New	+$682K	0.03%	173
2015 Q4	–	Sell	-1,099,652	Closed	-$6.65M	–	334
2015 Q3	$6.65M	Sell	1,099,652 -82,515	-7%	-$1.01M	0.19%	128
2015 Q2	$18.7M	Buy	1,182,167 +1,032,167	+688%	+$12.5M	0.38%	69
2015 Q1	$1.63M	Sell	150,000 -61,500	-29%	-$628K	0.03%	180
2014 Q4	$2.23M	Buy	211,500 +103,063	+95%	+$1.01M	0.07%	132
2014 Q3	$1.04M	Buy	+108,437	New	+$1.11M	0.04%	171

Other funds holding RPTP

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Highland Capital Management (Texas)'s RPTP Position: Q2 2016 in Review

Highland Capital Management (Texas) sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q2 2016, closing a stake of 169,600 shares — an estimated $781K sold.

Highland Capital Management (Texas) first reported a position in RPTP in Q3 2014 and held it in 6 quarters. The position peaked at $18.7M in Q2 2015. 93 funds tracked by Wall St. Rank hold RPTP as of Q2 2016.

Highland Capital Management (Texas) reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q2 2016 after selling out during the quarter.
Highland Capital Management (Texas) sold 169,600 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q2 2016, an estimated $781K.
Highland Capital Management (Texas) first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2014 and held it in 6 quarters.
Highland Capital Management (Texas)'s RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $18.7M in Q2 2015.
93 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q2 2016.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2016, filed 15 Aug 2016.